{
    "startDate": "2020-01-01",
    "endDate": "2020-12-31",
    "year": "2020",
    "quarter": "FY",
    "symbol": "CLBS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 16512000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecurities",
                "unit": "usd",
                "value": 18061000
            },
            {
                "label": "Prepaid and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 758000
            },
            {
                "label": "Current Assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 35331000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 57000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 614000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 36002000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1020000
            },
            {
                "label": "Accrued Liabilities [Abstract]",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2486000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3506000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 254000
            },
            {
                "label": "LIABILITIES, NON-CONTROLLING INTERESTS AND EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 3760000
            },
            {
                "label": "Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2020 and December 31, 2019, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value, authorized 500,000,000 shares; issued 19,389,413 and 10,528,689 shares, at December 31, 2020 and December 31, 2019, respectively; and outstanding, 19,378,333 and 10,517,609 shares, at December 31, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 19000
            },
            {
                "label": "Additional Paid in Capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 458748000
            },
            {
                "label": "Treasury stock, at cost; 11,080 shares at December 31, 2020 and December 31, 2019 respectively",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 708000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -425550000
            },
            {
                "label": "Accumulated other comprehensive (loss) income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -13000
            },
            {
                "label": "Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 32496000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -254000
            },
            {
                "label": "Total equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 32242000
            },
            {
                "label": "LIABILITIES, NON-CONTROLLING INTERESTS AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 36002000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -8141000
            },
            {
                "label": "Equity-based compensation expense",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 1265000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 63000
            },
            {
                "label": "Amortization/accretion on marketable securities",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -307000
            },
            {
                "label": "Prepaid and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -56000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -466000
            },
            {
                "label": "Accounts payable, accrued liabilities and other liabilities",
                "concept": "clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities",
                "unit": "usd",
                "value": -2839000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -8823000
            },
            {
                "label": "Purchase of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 34799000
            },
            {
                "label": "Sales of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 27542000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -7277000
            },
            {
                "label": "Tax withholding payments on net share settlement equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 148000
            },
            {
                "label": "Net proceeds from issuance of capital stock",
                "concept": "ProceedsFromIssuanceOrSaleOfEquity",
                "unit": "usd",
                "value": 18728000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 18580000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 2480000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Research and Development Costs",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 9253000
            },
            {
                "label": "General, and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9892000
            },
            {
                "label": "Operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 19145000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -19145000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Other income:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Net loss before benefit from income taxes and noncontrolling interests",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -19013000
            },
            {
                "label": "Total",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -10872000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -8141000
            },
            {
                "label": "Less - net income attributable to noncontrolling interests",
                "concept": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Net loss attributable to Caladrius Biosciences, Inc. common shareholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8150000
            },
            {
                "label": "Basic and diluted loss per share:",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.53
            },
            {
                "label": "Basic and diluted weighted average common shares outstanding (shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 15440000
            },
            {
                "label": "Available for sale securities - net unrealized (loss) income",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -15000
            },
            {
                "label": "Other comprehensive loss:",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -15000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -8156000
            },
            {
                "label": "Comprehensive income attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -8165000
            }
        ]
    }
}